BLFS
Price
$23.29
Change
+$1.95 (+9.14%)
Updated
May 9 closing price
Capitalization
810.87M
89 days until earnings call
TWST
Price
$30.82
Change
-$1.79 (-5.49%)
Updated
May 9 closing price
Capitalization
1.98B
83 days until earnings call
Ad is loading...

BLFS vs TWST

Header iconBLFS vs TWST Comparison
Open Charts BLFS vs TWSTBanner chart's image
BioLife Solutions
Price$23.29
Change+$1.95 (+9.14%)
Volume$1.16M
Capitalization810.87M
Twist Bioscience
Price$30.82
Change-$1.79 (-5.49%)
Volume$1.16M
Capitalization1.98B
BLFS vs TWST Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. TWST commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and TWST is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (BLFS: $23.29 vs. TWST: $30.82)
Brand notoriety: BLFS and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 213% vs. TWST: 95%
Market capitalization -- BLFS: $810.87M vs. TWST: $1.98B
BLFS [@Medical Specialties] is valued at $810.87M. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while TWST’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 7 bearish.
  • TWST’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TWST is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -7.84% price change this week, while TWST (@Medical Specialties) price change was -21.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

TWST is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.98B) has a higher market cap than BLFS($811M). BLFS YTD gains are higher at: -10.285 vs. TWST (-33.678). BLFS has higher annual earnings (EBITDA): -45.24M vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. BLFS (51.7M). BLFS has less debt than TWST: BLFS (42.7M) vs TWST (91.9M). TWST has higher revenues than BLFS: TWST (262M) vs BLFS (143M).
BLFSTWSTBLFS / TWST
Capitalization811M1.98B41%
EBITDA-45.24M-172.41M26%
Gain YTD-10.285-33.67831%
P/E Ratio238.10N/A-
Revenue143M262M55%
Total Cash51.7M311M17%
Total Debt42.7M91.9M46%
FUNDAMENTALS RATINGS
BLFS vs TWST: Fundamental Ratings
BLFS
TWST
OUTLOOK RATING
1..100
853
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
7597
SMR RATING
1..100
9092
PRICE GROWTH RATING
1..100
5586
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
9595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for BLFS (95) in the Medical Specialties industry. This means that TWST’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as TWST (97) in the Biotechnology industry. This means that BLFS’s stock grew similarly to TWST’s over the last 12 months.

BLFS's SMR Rating (90) in the Medical Specialties industry is in the same range as TWST (92) in the Biotechnology industry. This means that BLFS’s stock grew similarly to TWST’s over the last 12 months.

BLFS's Price Growth Rating (55) in the Medical Specialties industry is in the same range as TWST (86) in the Biotechnology industry. This means that BLFS’s stock grew similarly to TWST’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for TWST (100) in the Biotechnology industry. This means that BLFS’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSTWST
RSI
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 17 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 6 days ago
80%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMGCX23.88N/A
N/A
JPMorgan Mid Cap Growth C
OEQAX7.89N/A
N/A
Oaktree Emerging Markets Equity A
SCGSX118.23N/A
N/A
DWS Capital Growth S
FBSAX36.24N/A
N/A
Franklin Mutual U.S. Mid Cap Value Adv
RPXFX25.63N/A
N/A
RiverPark Large Growth Retail

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+9.14%
RGEN - BLFS
57%
Loosely correlated
-3.61%
DHR - BLFS
49%
Loosely correlated
-2.61%
RVTY - BLFS
47%
Loosely correlated
-1.78%
A - BLFS
47%
Loosely correlated
-1.63%
GH - BLFS
46%
Loosely correlated
+0.10%
More

TWST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TWST has been loosely correlated with VCYT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TWST jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TWST
1D Price
Change %
TWST100%
-5.49%
VCYT - TWST
50%
Loosely correlated
-4.81%
GH - TWST
49%
Loosely correlated
+0.10%
ALGN - TWST
47%
Loosely correlated
+0.53%
BLFS - TWST
45%
Loosely correlated
+9.14%
IQV - TWST
45%
Loosely correlated
-2.81%
More